bpc-157 human clinical trial randomized double blind Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions What is a Double-Blind Trial?
Description
B 1999, 103, 525534
Clinical and preclinical data do not guarantee future approval
Foundational therapies can reduce triggers, but they may not be enough to re-educate and rebalance the immune cells perpetuating the attack
Spacing doses evenly (such as Monday, Wednesday, Friday) maintains more stable signaling compared to clustered dosing
PMID: 23 MiaoHZhangSJWuXLiPZhaoYY
The treatment shouldnt be too painful however each clients threshold to pain differs so please discuss any concerns during your consultation
